Welcome to Professor Constantine (Con) Tam

Professor Constantine (Con) Tam

Welcome to Professor Con Tam, who has started with Central Clinical School on 28 February 2022. 

Professors Harshal Nandurkar, Terry O'Brien and Steve Jane write:

It is a pleasure to announce the recruitment of Professor Constantine (Con) Tam to join Alfred Health and Central Clinical School as Head of the Lymphoma Service.

Con received his M.B.B.S.(Hons) and M.D. degrees from the University of Melbourne. After dual training in Haematology and Haematopathology, Con completed his Leukemia Fellowship at MD Anderson Cancer Centre in Houston, Texas. Prior to moving to the Alfred, Con served as Disease Group Lead for Low Grade Lymphoma and CLL at Peter MacCallum Cancer Centre & Royal Melbourne Hospital for over 10 years. He is also past Director of Haematology at St. Vincent's Hospital.

Con is passionate about developing new treatments for blood cancers. He is the global lead for the BTK inhibitor zanubrutinib, and oversaw its development from the first-in-human dosing (in Melbourne) to successful international licensing studies worldwide. Con designed and performed the first global study to combine ibrutinib and venetoclax, publishing the results in the New England Journal of Medicine 5 years after inception. In 2015, he became the Australian lead for the pivotal study of Tisagenlecleucel in diffuse large B-cell lymphoma, leading to public funding for CAR T-cells as standard treatment in Australia.

The publication record for Con includes 240 peer-reviewed papers in New England Journal of Medicine, Lancet, Journal of Clinical Oncology, Blood and other top-tier journals. His work has been cited >17,000 times in the literature. Con is the current Lymphoma Editor for Blood Advances.

Please join us in welcoming Con to this campus.

Prof Harshal Nandurkar, Director of Clinical Haematology and Program Director-Alfred Cancer, Head Australian Centre for Blood Diseases

Prof Terence O'Brien, Chair of Medicine and Head, The Central Clinical School, Monash University, Program Director-Alfred Brain, Deputy Director of Research, The Alfred

Prof Stephen Jane, Dean, Sub-Faculty of Translational Medicine and Public Health, Monash University and Director of Research, The Alfred